Almost 48,000 men are diagnosed with prostate cancer in the UK every year. But questions are being asked of the tests used to diagnose these men, and how they might be improved. The tests used today can be painful, invasive and, unfortunately, not that good at telling doctors for sure which cases need urgent attention,
Prostate cancer is the commonest form of cancer in the Western world. Between 15 to 20 percent of men are affected by it at some time in their lives and 2.6 percent die from prostate cancer. That equates to 1,000 deaths a year in Austria. Apart from genetic factors, environmental (epigenetic) risk factors also play
A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer. Blue light is a range of the visible light spectrum emitted by
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life three months after treatment, but a better quality of life in the long term, compared to those on standard therapy, according to a new Northwestern Medicine study. The findings were published in the Journal of Clinical Oncology. “Treatment of prostate
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately. The current prostate-specific antigen (PSA) test is considered too unreliable for population screening, and the scientists will study if MRI could be used to screen men to pick up cancers
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok